RHÖN-KLINIKUM AG and Siemens launch major project

SIEMENSThe RHÖN-KLINIKUM AG and Siemens Medical Solutions signed a contract just over a year ago for the construction and operation of a particle therapy facility. With the permit approval process and application hearing now underway, the high-tech project is beginning to take shape. Construction is expected to begin in the summer of 2007. RHÖN-KLINIKUM AG (RKA) is investing more than 100 million euros in the facility, which is being built in Marburg, Germany, and will be operated in close cooperation with the Giessen/Marburg University Hospital.

Particle therapy is an extremely precise and biologically effective procedure for fighting cancer. Certain tumors that were previously difficult or impossible to treat due to their location or proximity to vital organs can now be treated using this technology - a milestone in cancer treatment.

The contract covers the construction and technical operation of the particle therapy facility, including maintenance. This project represents the third facility worldwide that specializes in the treatment of tumors using protons and heavy ions. Giessen/Marburg University Hospital will conduct studies to scientifically monitor particle therapy at this facility. The four treatment rooms are expected to handle more than 2,000 patients annually. "We expect the facility to open in 2010, resulting in a major step in treating cancer," said Wolfgang Pfoehler, CEO of RKA.

This type of facility from Siemens Medical Solutions enables hospitals and clinics to enter the world of proton and carbon-based particle therapy. In addition, the solution is designed for use with other types of ions as part of future research projects, making it a sound financial investment. "Siemens has been successfully involved in the field of radio-oncology for more than 100 years and has advanced this field through its many technical innovations," explained Dr. Johannes Nardi, particle therapy project manager for Siemens Medical Solutions. "As partner with RKA, we are pleased to achieve a further milestone in cancer treatment through the particle therapy facility in Marburg. The innovative solutions from Siemens in the areas of particle beam generation, imaging, patient positioning, treatment planning and information technology will be put to optimal use in the facility."

Background information on particle therapy
Particle therapy facilitates extremely precise and effective cancer treatments. In clinical application, protons or carbon ions are brought up to very high speeds using an accelerator and then applied to tumors, thus destroying the tumor cells. Thanks to the range of coverage that can be accurately calculated and a control system with millimeter accuracy, the target areas can be irradiated without impacting the surrounding tissue. An inpatient hospital stay for this treatment is required only in exceptional cases because virtually no side effects have been noted to date. Particle therapy can treat some tumors that could not previously be treated or were difficult to treat. As a result, the chances of curing some cancers – for example, malignant tumors originating in the cartilage at the base of the skull – have increased to more than 90 percent. This has been documented in clinical studies by the GSI (Society for Heavy Ion Research) and the University of Heidelberg.

RHÖN-KLINIKUM AG (RKA) is a leading private hospital service provider and is committed to the highest standards of patient-oriented care combining the very best quality of service with good value. The company's object is to build and operate hospitals, especially in the area of acute hospitals at all care levels. When it went public in 1989 it became the first listed hospital group in Germany. Rhön-Klinikum AG shares the values and goals of the German health system. RKA aims to uphold the efficiency and social acceptability of this system on the principle of "rationalisation before rationing". Currently the listed hospital group headquartered in the Rhön counts 45 hospitals (43 acute/2 rehab) at 34 sites with a total of 14,620 beds/places. It employs 30,967 persons. More information can be found under www.rhoen-klinikum-ag.com

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting www.siemens.com/medical

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

New Medical AI Tool Identifies more Case…

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

MEDICA 2024 and COMPAMED 2024: Medical T…

11 - 14 November 2024, Düsseldorf, Germany. "Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto...

NIH-Developed AI Algorithm Successfully …

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials...

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...